MarketCap
Facebook
X
TelegramAnnual report 2022
added 10-07-2022
Allied Healthcare Products Accounts Payables 2011-2026 | AHPI
Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.Main types of accounts payable
| Type of liability | Example |
|---|---|
| To suppliers and contractors | Goods received but not yet paid for |
| Taxes and fees | VAT, income tax, etc., not paid on time |
| Salaries | Employee wages not paid |
| To budgets | Insurance contributions to funds not paid |
| To founders | Founders provided borrowed funds |
| To banks | Overdue loan payments |
| Other | Fines, penalties, forfeits, customer prepayments, etc. |
Impact on the company's financial performance
- Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios - Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence - Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals) - Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated
Annual Accounts Payables Allied Healthcare Products
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.21 M | 1.9 M | 2.94 M | 1.47 M | 1.47 M | 1.44 M | 1.86 M | 1.37 M | 1.07 M | 1.32 M | 1.8 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.94 M | 1.07 M | 1.62 M |
Quarterly Accounts Payables Allied Healthcare Products
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 2.79 M | 1.36 M | 1.97 M | 1.9 M | 1.88 M | 3.06 M | 3.48 M | 2.94 M | 1.69 M | 1.89 M | 1.57 M | 1.47 M | 1.47 M | 1.88 M | 2.03 M | 1.47 M | 1.47 M | 2.08 M | 1.57 M | 1.44 M | 1.44 M | 1.36 M | 1.8 M | 1.86 M | 1.86 M | 1.97 M | 1.58 M | 1.37 M | 1.37 M | 1.21 M | 1.54 M | 1.07 M | 1.07 M | 1.69 M | 1.7 M | 1.32 M | 1.32 M | 1.69 M | 1.83 M | 1.8 M | 1.8 M | 2.03 M | 1.8 M | 1.64 M | 1.64 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.48 M | 1.07 M | 1.76 M |
Accounts Payables of other stocks in the Medical devices industry
| Issuer | Accounts Payables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AdaptHealth Corp.
AHCO
|
352 M | $ 13.11 | 0.23 % | $ 1.77 B |  USA |
 |
BIOLASE
BIOL
|
6.06 M | - | -13.19 % | $ 166 K | USA |
 |
Eargo
EAR
|
6.5 M | - | - | $ 10.2 M | USA |
 |
Apollo Endosurgery
APEN
|
7.42 M | - | - | $ 475 M | USA |
 |
Second Sight Medical Products
EYES
|
1.03 M | - | -0.97 % | $ 54.4 M | USA |
 |
Electromed
ELMD
|
2.67 M | $ 25.71 | 2.43 % | $ 217 M | USA |
 |
Avinger
AVGR
|
777 K | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
9.07 M | - | - | $ 3.31 B | USA |
 |
EDAP TMS S.A.
EDAP
|
5.71 M | $ 3.32 | 0.3 % | $ 124 M |  France |
 |
Aziyo Biologics
AZYO
|
4.79 M | - | 1.37 % | $ 20.5 M | USA |
 |
Conformis
CFMS
|
4.16 M | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
1.26 M | $ 11.18 | 8.12 % | $ 317 M | USA |
 |
Helius Medical Technologies
HSDT
|
531 K | $ 2.04 | 3.03 % | $ 1.24 M | USA |
 |
Cardiovascular Systems
CSII
|
14.4 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
2.87 M | $ 0.61 | -4.04 % | $ 38 M | USA |
 |
Inspire Medical Systems
INSP
|
36.6 M | $ 56.14 | 5.11 % | $ 1.65 B | USA |
 |
Invacare Corporation
IVC
|
105 M | - | - | $ 24.7 M | USA |
 |
IRIDEX Corporation
IRIX
|
5.38 M | $ 1.03 | - | $ 17.4 M | USA |
 |
Dynatronics Corporation
DYNT
|
3.4 M | - | 14.99 % | $ 929 K | USA |
 |
LivaNova PLC
LIVN
|
97.2 M | $ 60.1 | 2.0 % | $ 3.28 B |  Britain |
 |
OrthoPediatrics Corp.
KIDS
|
18.8 M | $ 15.06 | 2.87 % | $ 353 M | USA |
 |
Butterfly Network
BFLY
|
4.25 M | $ 4.79 | -2.64 % | $ 1.01 B | USA |
 |
GBS
GBS
|
1.47 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
98.9 M | $ 90.18 | 2.72 % | $ 12.2 B | USA |
 |
Delcath Systems
DCTH
|
2.66 M | $ 10.38 | 1.67 % | $ 372 M | USA |
 |
NanoVibronix
NAOV
|
719 K | - | - | $ 1.08 M | USA |
 |
CONMED Corporation
CNMD
|
93.6 M | $ 36.66 | 1.95 % | $ 1.14 B | USA |
 |
Integer Holdings Corporation
ITGR
|
113 M | $ 88.51 | 5.78 % | $ 3.07 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
228 M | $ 83.5 | 2.81 % | $ 48.8 B | USA |
 |
LENSAR
LNSR
|
19 M | $ 5.23 | -2.97 % | $ 62.5 M | USA |
 |
Pulmonx Corporation
LUNG
|
3.9 M | $ 1.28 | 6.67 % | $ 52.1 M | USA |
 |
MiMedx Group
MDXG
|
14.5 M | $ 3.36 | 8.91 % | $ 497 M | USA |
 |
Myomo
MYO
|
1.51 M | $ 0.86 | 8.54 % | $ 36 M | USA |
 |
Cutera
CUTR
|
19.8 M | - | -10.19 % | $ 1.99 M | USA |
 |
NuVasive
NUVA
|
20.3 M | - | - | $ 2.07 B | USA |
 |
Nevro Corp.
NVRO
|
24.5 M | - | - | $ 217 M | USA |
 |
Natus Medical Incorporated
NTUS
|
36.4 M | - | 1.94 % | $ 1.05 B | USA |